|
Catalog Number PXP35-08-17-135 |
Device Problems
Difficult to Advance (2920); Device Dislodged or Dislocated (2923)
|
Patient Problems
Embolism/Embolus (4438); Thrombosis/Thrombus (4440); Insufficient Information (4580)
|
Event Date 02/25/2020 |
Event Type
Injury
|
Event Description
|
Physician was attempting to use visipro balloon expandable stent during procedure to treat a moderately calcified lesion in the left proximal subclavian artery with 80% stenosis.The vessel was moderately tortuous.No embolic protection was used.There was no damage noted to packaging.There was no issue noted when removing the device from hoop/tray.The device was prepped per ifu with no issues identified.It was report that when physician tried to cross the lesion, felt resistance, so pre dilated and then tried to cross with the stent.After positioning the stent across the lesion, tried to inflate it but the stent got dislodged from the system and due to blood flow it went further.Physician had to use a snare to remove the dislodged stent.Lesion was pre dilated with a 5x40 balloon.There was resistance encountered when advancing the device with no excessive force used.Post stent removal, there was thrombus formation, which was treated with balloon angioplasty followed by thrombolysis.No further patient injury reported.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|